Summary
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
History
G Medical Innovations was founded in 1988 as a medical technology and healthcare company. Its mission is to provide society with innovative and advanced solutions to enable healthcare providers to deliver the highest standards of patient care.
Mission
We strive to drive healthcare innovations and breakthrough technologies to radically improve healthcare outcomes for patients, providers, and all stakeholders.
Vision
Our vision is to be the leading partner for healthcare providers globally, creating sustainable solutions to empower them to radically improve healthcare outcomes and advance lives.
Key Team
Mr. Oded Shahar (Sr. Investment Banker and Sr. VP of Merger & Acquisition)
Mr. Brett Tucker (Company Sec.)
Ms. Dror Nuriel-Roth (Exec. VP of US Operations)
Mr. Kobi Ben Efraim (Controller)
Recognition and Awards
G Medical Innovations has received multiple awards in recognition of their breakthrough healthcare solutions, including recognition from the World Economic Forum in 2020.
References
